The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation: Analysis of 2012 Participants in the SPAF I–III Clinical Trials
Abstract
Background and Purpose —Nonvalvular atrial fibrillation (AF) is a strong, independent risk factor for stroke, but the absolute rate of stroke varies widely among AF patients, importantly influencing the potential benefit of antithrombotic prophylaxis. We explore factors associated with ischemic stroke in AF patients taking aspirin. Methods —We performed multivariate logistic regression analysis of 2012 participants given aspirin alone or in combination with low, inefficacious doses of warfarin in the Stroke Prevention in Atrial Fibrillation I–III trials followed for a mean of 2.0 years, during which 130 ischemic strokes were observed. Results —Age (relative risk [RR]=1.8 per decade, P <0.001), female sex (RR=1.6, P =0.01), history of hypertension (RR=2.0, P <0.001), systolic blood pressure >160 mm Hg (RR=2.3, P <0.001), and prior stroke or transient ischemic attack (RR=2.9, P <0.001) were independently associated with increased stroke risk. Regular consumption of ≥14 alcohol-containing drinks per week was associated with reduced stroke risk (adjusted RR=0.4, P =0.04). Among SPAF III participants, estrogen hormone replacement therapy was associated with a higher risk of ischemic stroke (adjusted RR=3.2, P =0.007). With the use of these variables, a risk stratification scheme for primary prevention separated participants into those with high (7.1%/y, 22% of the cohort), moderate (2.6%/y, 37% of the cohort), and low (0.9%/y, 41% of the cohort) rates of stroke. Ischemic strokes in low-risk participants were less often disabling ( P <0.001). Conclusions —Patients with AF who have high and low rates of stroke during treatment with aspirin can be identified. However, validation of our risk stratification scheme is necessary before it can be applied with confidence to clinical management. Postmenopausal estrogen replacement therapy and moderate alcohol consumption may additionally modify the risk of stroke in AF, but these findings require confirmation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Rosner, B., Speizer, F. E., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109123251102 · Cited by 1,997
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
Stroke Prevention in Atrial Fibrillation Study. Final results.
(1991) · Circulation · doi:10.1161/01.cir.84.2.527 · Cited by 1,696
Risk of venous thromboembolism in users of hormone replacement therapy
Daly, E., Vessey, M. P., Hawkins, M. M., Carson, J. L., Gough, P., & Marsh, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07113-9 · Cited by 819
Hylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
Jick, H., Derby, L. E., Myers, M. W., Vasilakis, C., & Newton, K. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07114-0 · Cited by 602
Prospective study of exogenous hormones and risk of pulmonary embolism in women
Grodstein, F., Stampfer, M. J., Goldhaber, S. Z., Manson, J. E., Colditz, G. A., Speizer, F. E., Willett, W. C., & Hennekens, C. H. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07308-4 · Cited by 571
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-6 · Cited by 543
(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)83303-x · Cited by 539
Aspirin and Risk of Hemorrhagic Stroke: A Meta-analysis of Randomized Controlled Trials
He, J., Whelton, P. K., Vu, B., & Klag, M. J. (1998) · JAMA · doi:10.1001/jama.280.22.1930 · Cited by 521
Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-1 · Cited by 477
Prevalence of atrial fibrillation and eligibility for anticoagulants in the community
Sudlow, M., Thomson, R., Thwaites, B., Rodgers, H., & Kenny, R. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01401-9 · Cited by 383
Postmenopausal oestrogen treatment and stroke: a prospective study.
Paganini-Hill, A., Ross, R. K., & Henderson, B. E. (1988) · BMJ · doi:10.1136/bmj.297.6647.519 · Cited by 344
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study
Gutthann, S. P., Rodriguez, L. A. G., Castellsague, J., & Oliart, A. D. (1997) · BMJ · doi:10.1136/bmj.314.7083.796 · Cited by 338
The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.279.16.1273 · Cited by 315
(1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.12.1316 · Cited by 302
Gulløv, A. L., Koefoed, B. G., Petersen, P., Pedersen, T. S., Andersen, E. D., Godtfredsen, J., & Boysen, G. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.14.1513 · Cited by 301
Contrast sonography for detection of vesicoureteral reflux
Kaneko, K., Kuwatsuru, R., Fukuda, Y., Yamataka, A., Yabuta, K., Katayama, H., & Miyano, T. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92123-7 · Cited by 222
Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden
Falkeborn, M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.10.1201 · Cited by 195
Transesophageal Echocardiography To Assess Embolic Risk in Patients with Atrial Fibrillation
Stollberger, C., Chnupa, P., Kronik, G., Brainin, M., Finsterer, J., Schneider, B., & Slany, J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-8-199804150-00004 · Cited by 169
Prevention of stroke in patients with nonvalvular atrial fibrillation
Hart, R. G., Sherman, D. G., Easton, J. D., & Cairns, J. A. (1998) · Neurology · doi:10.1212/wnl.51.3.674 · Cited by 164
Self-citation1 (1995) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/s1052-3057(10)80166-1 · Cited by 164
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440320143013 · Cited by 161
Ischemic stroke in patients with atrial fibrillation
Miller, V. T., Rothrock, J. F., Pearce, L. A., Feinberg, W. M., Hart, R. G., & Anderson, D. C. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.32 · Cited by 156
Self-citationHormone replacement therapy and risk of non-fatal stroke
Pedersen, A. T., Lidegaard, Ø., Kreiner, S., & Ottesen, B. (1997) · The Lancet · doi:10.1016/s0140-6736(97)06005-4 · Cited by 142
Hormone Replacement Therapy and the Risk of Stroke
Falkeborn, M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410100035005 · Cited by 135
Risk factors for stroke in patients with nonrheumatic atrial fibrillation: A case-control study
Moulton, A. W., Singer, D. E., & Haas, J. S. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90008-l · Cited by 130
Ischemic Stroke and Use of Estrogen and Estrogen/Progestogen as Hormone Replacement Therapy
Petitti, D. B., Sidney, S., Quesenberry, C. P., & BERNSTEIN, A. L. (1998) · Stroke · doi:10.1161/01.str.29.1.23 · Cited by 100
Blackshear, J. L., Stroke Prevention in Atrial Fibrillation Investigators, Pearce, L. A., ASINGER, R. W., Dittrich, H. C., Goldman, M. E., Zabalgoitia, M., Rothbart, R. M., & Halperin, J. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)91079-w · Cited by 94
Self-citationPsaty, B. M. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410120009002 · Cited by 86
Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation.
Flegel, K. M., & Hanley, J. A. (1989) · Stroke · doi:10.1161/01.str.20.8.1000 · Cited by 71
A differential effect of aspirin on prevention of stroke in atrial fibrillation
(1993) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/s1052-3057(10)80159-4 · Cited by 63
Alcohol Consumption and Risk of Deep Venous Thrombosis and Pulmonary Embolism in Older Persons
Pahor, M., Guralnik, J. M., Havlik, R. J., Carbonin, P., Salive, M. E., Ferrucci, L., Corti, M., & Hennekens, C. H. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb02933.x · Cited by 45
Intensity of Anticoagulation To Prevent Stroke in Patients with Atrial Fibrillation
Hart, R. G. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-5-199803010-00012 · Cited by 42
Self-citationThe stroke prevention in atrial fibrillation III study: Rationale, design, and patient features*
STROKEPREVENTIONINATRIALFIBRI (1997) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/s1052-3057(97)80217-0 · Cited by 41
Hormone Replacement Therapy and Haemostatic Function
Meade, T. W. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657626 · Cited by 39
Stroke risk in an elderly population with atrial fibrillation
Feinberg, W. M., Kronmal, R. A., Newman, A. B., Kraut, M. A., Bovill, E. G., Cooper, L. S., & Hart, R. G. (1999) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1999.00281.x · Cited by 36
Self-citationPredictors of ischemic stroke in non-rheumatic atrial fibrillation
Yoshida, M., Nakamura, Y., Higashikawa, M., & Kinoshita, M. (1996) · International Journal of Cardiology · doi:10.1016/0167-5273(96)02726-x · Cited by 31
Cited by
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Metadata
- Authors
- Hart, R. G., Pearce, L. A., McBride, R., Rothbart, R. M., & Asinger, R. W.
- Venue
- Stroke
- Published
- 1999-06
- Volume
- 30
- Issue
- 6
- Pages
- 1223-1229
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2097613963
- Cited by
- 533
- References
- 41
- FWCI
- 14.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.